Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1963; 10(02): 431-437
DOI: 10.1055/s-0038-1654796
DOI: 10.1055/s-0038-1654796
Originalarbeiten — Original Article — Travaux Originaux
The Antithrombosis Activity of the Heparinoid G 31150[*]
Further Information
Publication History
Publication Date:
22 June 2018 (online)
Summary
Typical platelet thrombi were produced in veins of dogs and rats. The administration of G 31150 reduced the incidence of thrombi in dogs but not in rats. Infusion of dog plasma to which G 31150 had been added, successfully reduced the incidence of thrombosis in rats.
* Supported in part by grants from Geigy Pharmaceuticals (Canada) Ltd. and the Medical Research Council of Canada (C. G. —24).
-
References
- 1 Ashwin J. G. Anticoagulant and Fibrinolysins. Mac Millan. 177 1961;
- 2 Blake O. R, Ashwin J. G, Jaques L. B. J. clin. Path. 12: 118 1959;
- 3 Beller F. K. Thrombosis and Anticoagulant Therapy. 75 1960
- 4 Murray D. W. G, Jaques L. B, Perrett T. S, Best C. H. Surgery. 02: 16 1937;
- 5 Jaques L. B, Bell H. J. Meth. biochem. Anal. 07: 304 1959;
- 6 Jarrell C. L, Jaques L. B. Canad. J. Biochem. (in press).
- 7 Monkhouse F. C, Jaques L. B. J. Lab. clin. Med. 36: 782 1950;
- 8 Astrup P. Heparin Investigations, Store Nordiske Publishers. Copenhagen. 1944
- 9 Pulyer R. (in press).